Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses. - Wikidata - wikimedia - TriplyDB

Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.

Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.

http://www.wikidata.org/entity/Q34992785

about

Adenovirus targeting to prostate-specific membrane antigen through virus-displayed, semirandom peptide library screening.A novel approach for detecting viable and tissue-specific circulating tumor cells through an adenovirus-based reporter vector.Bicalutamide-activated oncolytic adenovirus for the adjuvant therapy of high-risk prostate cancer.Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy.Loss of Cyclin-Dependent Kinase Inhibitor Alters Oncolytic Adenovirus Replication and Promotes More Efficient Virus Production.

P2860

Q33645206-403E43DE-A5BF-4239-B4C9-487ADE6DBF9B Q34036427-3177A1C3-8316-4651-A408-1375AC023F06 Q39139906-C3898918-DCBB-4624-92D0-D4B7C38FF22E Q39178068-6C2C3BE0-43B7-499D-9520-2EFCA3486040 Q55515593-9ED36830-8373-4BB4-AFE1-17D5F3CF73A5

P2860

Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.

http://www.wikidata.org/entity/Q34992785

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.

@ast

Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.

@en

Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.

@nl

type

label

Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.

@ast

Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.

@en

Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.

@nl

prefLabel

Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.

@ast

Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.

@en

Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.

@nl

P1433

Q34992785-C0EFF531-9B5E-4B87-BC70-C2DB5003FFA0

P1476

Q34992785-23432AB2-7E1F-4770-9094-02F4D6893742

P2093

Q34992785-37E9146D-11BA-4D9B-9FB3-B87B84E76217

Q34992785-4E8A19E8-95D1-4B6E-9CE9-6D9FAF664306

Q34992785-63BBD4FB-1BE2-4E73-85D7-94C8DEE40CF2

Q34992785-709515C5-2E4A-4DE5-8016-BA0444B5D61B

Q34992785-79F55764-81BE-49D1-8C7B-8F33037B7E99

Q34992785-97CEABB0-CCA9-4D84-821B-017C6053E1E4

Q34992785-B74B5CDC-F77B-4EA7-AB01-C83A0BCEEEC2

P2860

Q34992785-079FDAD0-D971-403F-A2BE-F8612DAA509D

Q34992785-0C495926-67E3-417D-B627-1646D7B24988

Q34992785-17463DDC-17E1-4E1F-9A32-B55EC33D87D1

Q34992785-2716FDBD-BF9F-4FC0-A80F-B23BCCBEE4A1

Q34992785-2892C866-D4AA-4F37-B05D-8FDF182043EA

Q34992785-3DF54DB8-CC79-4051-8508-4DCD17A6CE9A

Q34992785-44B1FA5A-3798-4173-8564-7311F5D8F7A9

Q34992785-453B146D-0615-4314-B87B-0EEC716C9BB4

Q34992785-4D8B298C-CF56-4791-959B-B9FA06A1CAA4

Q34992785-576B9009-2719-44A3-83D4-8BAA809170C4

P2888

Q34992785-A86FE2AA-5010-42A8-8FB8-4F06E24D8F29

P304

Q34992785-5CDDD234-E27D-415F-B868-7323DA742D98

P31

Q34992785-69367B07-D4AC-4427-9E29-F1C8FE9A917C

P356

Q34992785-CE8C6251-34C8-490D-921C-B992B5CFD928

P433

Q34992785-69014A41-7193-4D68-8CCE-7D9EF45E2AF6

P478

Q34992785-917CC929-BF67-4F95-888B-EDEF02E776EF

P50

Q34992785-527BE0EB-EBD8-4A8E-9A14-2EE2FFDDD39E

Q34992785-E54A15E2-8ACC-4D63-B690-417A984B26A9

P577

Q34992785-6D91BB93-8E3B-4426-AC64-25BFB3C089A7

P5875

Q34992785-6C27F6A4-0758-4094-A902-70442CC2B41A

P698

Q34992785-2DCC2315-5078-49C2-83FA-D49CEAF3498A

P921

Q34992785-2C740445-5514-4B97-8051-7E14027F46E1

Q34992785-E851D50C-34E9-48AB-9047-327A483B26CE

P932

Q34992785-761CA0CD-4861-44E0-8595-DD22E5ED9A2A

P356

P1433

Cancer Gene Therapy

P1476

Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses

@en

P2093

M Castanares

http://www.w3.org/2001/XMLSchema#string

M Liu

http://www.w3.org/2001/XMLSchema#string

N Höti

http://www.w3.org/2001/XMLSchema#string

R Rodriguez

http://www.w3.org/2001/XMLSchema#string

S E Lupold

http://www.w3.org/2001/XMLSchema#string

S Mustafa

http://www.w3.org/2001/XMLSchema#string

T Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy for hormone-refractory prostate cancer

A simplified system for generating recombinant adenoviruses

Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication

A novel method for generating and screening peptides and libraries displayed on adenovirus fiber

HIF-1alpha induces cell cycle arrest by functionally counteracting Myc.

Inactivation of p21 by E1A leads to the induction of apoptosis in DNA-damaged cells.

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells.

Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells.

Adenovirus and cell cycle control.

Adenovirus type 5 exerts genome-wide control over cellular programs governing proliferation, quiescence, and survival.

P2888

P304

585-597

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CGT.2010.15

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Wasim H. Chowdhury

P577

2010-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44579036

http://www.w3.org/2001/XMLSchema#string

P698

20448671

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

3098117

http://www.w3.org/2001/XMLSchema#string